Drugs

Category / Pharmaceuticals & Biotech / Drugs

Xcovery Announces Presentation of Clinical Data at Upcoming ASCO Annual Meeting

WEST PALM BEACH, FL: Phase I Study Is First-in-Human Trial of an Oral VEGFR Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Solid Tumors ...

Cadus Reports First Quarter 2012 Results

NEW YORK, NY: ...

BASi Reports Fiscal 2012 Second Quarter Results

WEST LAFAYETTE, IN: ...

CORRECTION: Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting

LOS ANGELES, CALIFORNIA: ...

Arena Pharmaceuticals Awaits FDA Advisory Committee Meeting

LOS ANGELES, CALIFORNIA: ...

Ardea Biosciences Announces First Quarter 2012 Financial Results

SAN DIEGO, CA: ...

Agile Therapeutics Named Finalist for PACT 2012 Life Sciences Company of the Year

PRINCETON, NJ: Greater Philadelphia Alliance for Capital and Technologies (PACT) Awards Celebrate Innovation and Leadership in Life Sciences ...

Helix BioPharma Corp. Updates Shareholders on Election of Directors

AURORA, ON: ...

NuPathe to Report First Quarter 2012 Results and Hold Conference Call on Thursday, May 10, 2012

CONSHOHOCKEN, PA: ...

Pivotal Therapeutics Announces 2011 Financial Results

WOODBRIDGE, ONTARIO: ...

SciClone Files S-3 Registration Statement Prospectus Supplement Related to Sigma-Tau Transaction

FOSTER CITY, CA: ...

TiGenix Obtains Manufacturing License for European Production Facility

LEUVEN, BELGIUM: ...

AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout

SAN DIEGO,CA: ...

Cytokinetics Announces Clinical Trial Data Relating to CK-2017357 to Be Presented at the 64th Annual Meeting of the American Academy of Neurology

SOUTH SAN FRANCISCO, CA: Additional Preclinical Trial Data to Be Presented at the 2012 Experimental Biology Conference ...

Aptalis Pharma Inc. Announces Receipt of Requisite Consents to Amend Indenture Governing Its 12 3/4% Senior Notes, Entry Into Supplemental Indenture, Amendment of Its Senior Secured Credit Facilities, Settlement of 12 3/4% Senior Notes Tendered and Redemp

BRIDGEWATER, NJ: ...

Rapid Micro Biosystems Announces the 2013 Availability of Growth Direct(TM) Systems for Environmental Monitoring and Sterility Applications

BEDFORD, MA: New Applications Improve the Efficiency of Microbial Quality Control Processes While Significantly Reducing the Time-to-Result ...

Cromos(TM) Pharma's New Service: Registration of Medicinal Products in Russia

MOSCOW: ...

Cerecor Announces Clearance of IND for FP01

BALTIMORE, MD: ...

Threshold Pharmaceuticals Earns $20 Million Milestone Payment From Merck KGaA for Positive Results From Phase 2 Trial of TH-302 in Pancreatic Cancer

SOUTH SAN FRANCISCO, CA: ...

Mymetics Appoints Grant Pickering CEO and Christopher Henney Chairman

EPALINGES, SWITZERLAND: - Grant E. Pickering named President and CEO - Dr. Christopher Henney appointed Chairman of the Board of Directors - Election of new members to the Board of Directors ...

Page 54 von 64: 1 « .. 53 54 55 56 57 58 59 60 61 62 .. » 64

All members:	10 565
Register today:	0
Register yesterday:	2
Members online:	0
Guests online:	75